EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations

Chia-Hsin Liu, Cheng-Yin Liu, Nien-Tzu Liu, Yu-Chun Lin

Targeted Oncology · 21.11.2026

DOI: 10.1007/s11523-026-01275-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Targeted Oncology, online erschienen am 21.11.2026. Verfasst von Chia-Hsin Liu und 3 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Science and Technology Council, Tri-Service General Hospital, Medical Affairs Bureau.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Science and Technology Council
  • Tri-Service General Hospital
  • Medical Affairs Bureau

Zitieren

APA

Liu, C., Liu, C., Liu, N., & Lin, Y. (2026). Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations. Targeted Oncology. https://doi.org/10.1007/s11523-026-01275-4

Vancouver

Liu C, Liu C, Liu N, Lin Y. Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations. Targeted Oncology. 2026. doi:10.1007/s11523-026-01275-4

BibTeX
@article{Liu2026,
  author = {Liu, Chia-Hsin and Liu, Cheng-Yin and Liu, Nien-Tzu and Lin, Yu-Chun},
  title = {Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations},
  journal = {Targeted Oncology},
  year = {2026},
  doi = {10.1007/s11523-026-01275-4}
}
Kostenlos starten →